Ongoing Disclosure Notice – Jayne Hrdlicka
Ongoing Disclosure Notice
Disclosure of Directors and Senior Managers Relevant Interests
Sections 297(2) and 298(2), Financial Markets Conduct Act 2013
To NZX Limited; and
Name of listed issuer:
The a2 Milk Company Limited
Date this disclosure made:
3/09/2018
Date of last disclosure:
17/07/2018
Director or senior manager giving disclosure
Full name(s):
Carla Jayne Hrdlicka
Name of listed issuer:
The a2 Milk Company Limited (Company)
Name of related body corporate (if applicable):
N/A
Position held in listed issuer:Managing Director and CEO
Summary of acquisition or disposal of relevant interest (excluding specified derivatives)
Class of affected quoted financial products: Ordinary Shares
Nature of the affected relevant interest(s):
(1) Legal and beneficial owner of unlisted
time-based rights (representing an
entitlement to acquire Ordinary Shares in the
Company granted to Ms Hrdlicka as a one-
off transition benefit as compensation for the
forfeiture of her short term and long term
incentive entitlements from her former
employer as a result of her resignation to
take up employment with the Company)
(Time-Based Rights); (2) Legal and
beneficial owner of Ordinary Shares
For that relevant interest-
Number held in class before acquisition or disposal:
(1) 599,254 Time-Based Rights; (2) Nil
Ordinary Shares
Number held in class after acquisition or disposal:
(1) 242,022 Time-Based Rights; (2) 357,232
Ordinary Shares (received on automatic
exercise of the equivalent number of Time-
Based RIghts)
Current registered holder(s):Carla Jayne Hrdlicka
Registered holder(s) once transfers are registered:Carla Jayne Hrdlicka
Summary of acquisition or disposal of specified derivatives relevant interest (if applicable)
Type of affected derivative:
Class of underlying financial products:
Details of affected derivative-
The notional value of the derivative (if any) or the notional amount of underlying financial
products (if any):
A statement as to whether the derivative is cash settled or physically settled:
Maturity date of the derivative (if any):
Expiry date of the derivative(if any):
The price specified in the terms of the derivative (if any):
Any other details needed to understand how the amount of the consideration payable
under the derivative or the value of the derivative is affected by the value of the underlying
financial products:
For that derivative,-
Parties to the derivative:
If the director or senior manager is not a party to the derivative, the nature of the relevant
interest in the derivative:
Details of transactions giving rise to acquisition or disposal
Total number of transactions to which notice relates: 2
Details of transactions requiring disclosure-
Date of transaction:
(1) 28/08/2018; (2) 03/09/2018
Nature of transaction:
(1) Issue of 237,090 Ordinary Shares
following the automatic exercise of 237,090
Time-Based Rights, the timing of such
automatic exercise reflecting the vesting
date of the relevant forfeited incentive
entitlements from Ms Hrdlicka's former
employer; (2) Issue of 120,142 Ordinary
Shares following the automatic exercise of
120,142 Time-Based Rights, the timing of
such automatic exercise reflecting the
vesting date of the relevant forfeited
incentive entitlements from Ms Hrdlicka's
former employer
Name of any other party or parties to the transaction (if known):
N/A
The consideration, expressed in New Zealand dollars, paid or received for the acquisition
or disposal. If the consideration was not in cash and cannot be readily be converted into a
cash value, describe the consideration:
N/A
Number of financial products to which the transaction related:
(1) and (2) 357,232 Time-Based Rights in
aggregate
If the issuer has a financial products trading policy that prohibits directors or senior
managers from trading during any period without written clearance (a closed period)
include the following details—
Whether relevant interests were acquired or disposed of during a closed period:No
Whether prior written clearance was provided to allow the acquisition or disposal to
proceed during the closed period:
N/A
Date of the prior written clearance (if any):
N/A
Summary of other relevant interests after acquisition or disposal:
Class of quoted financial products:
Unlisted performance rights representing an
entitlement to acquire Ordinary Shares in the
Company (Performance Rights)
Nature of relevant interest:
Legal and beneficial
For that relevant interest,-
Number held in class:245,787 Performance Rights
Current registered holder(s):Carla Jayne Hrdlicka
For a derivative relevant interest,-
Type of derivative:
Details of derivative,-
The notional value of the derivative (if any) or the notional amount of underlying financial
products (if any):
A statement as to whether the derivative is cash settled or physically settled:
Maturity date of the derivative (if any):
Expiry date of the derivative (if any):
The price's specified terms (if any):
Any other details needed to understand how the amount of the consideration payable
under the derivative or the value of the derivative is affected by the value of the underlying
financial products:
For that derivative relevant interest,-
Parties to the derivative:
If the director or senior manager is not a party to the derivative, the nature of the relevant
interest in the derivative:
Certification
I certify that, to the best of my knowledge and belief, the information contained in this
disclosure is correct and that I am duly authorised to make this disclosure by all persons
for whom it is made.
Signature of director or officer:
Date of signature:
3/09/2018
or
Signature of person authorised to sign on behalf of director or officer:
Date of signature:
Name and title of authorised person:
Notes
Use this form to disclose all the acquisitions and disposals by a director or senior manager
of a listed issuer, or of a related body corporate, or in specified derivatives. The disclosure
must be made within—
(a) 20 working days after the first acquisition or disposal disclosed in this
notice if the acquisitions or disposals are of a kind referred to in section 297(2)(a) of the
Financial Markets Conduct Act 2013; or
(b) in any other case, 5 trading days after the first acquisition or disposal
disclosed in this notice.
---
Appendix 3Y
Change of Director’s Interest Notice
+ See chapter 19 for defined terms.
01/01/2011 Appendix 3Y Page 1
Rule 3.19A.2
Appendix 3Y
Change of Director’s Interest Notice
Information or documents not available now must be given to ASX as soon as available. Information and
documents given to ASX become ASX’s property and may be made public.
Introduced 30/09/01 Amended 01/01/11
Name of entity The a2 Milk Company Limited (Company)
ABN 97 769 415 292
We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for
the director for the purposes of section 205G of the Corporations Act.
Name of Director
Carla Jayne Hrdlicka
Date of last notice
17 July 2018
Part 1 - Change of director’s relevant interests in securities
In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust
Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should
be disclosed in this part.
Direct or indirect interest
Direct
Nature of indirect interest
(including registered holder)
Note: Provide details of the circumstances giving rise to the
relevant interest.
N/A
Date of change
28/08/2018 and 03/09/2018
No. of securities held prior to change
599,254 time-based rights representing an
entitlement to acquire ordinary shares in the
Company (granted to Ms Hrdlicka as a one-
off transition benefit as compensation for the
forfeiture of her short term and long term
incentive entitlements from her former
employer as a result of her resignation to take
up employment with the Company) (Time-
Based Rights)
245,787 performance rights representing an
entitlement to acquire ordinary shares in the
Company (Performance Rights)
Class
Ordinary shares in the Company (Ordinary
Shares)
Appendix 3Y
Change of Director’s Interest Notice
+ See chapter 19 for defined terms.
Appendix 3Y Page 2 01/01/2011
Number acquired
237,090 Ordinary Shares acquired on
28/08/2018
120,142 Ordinary Shares acquired on
03/09/2018
Number disposed
237,090 Time-Based Rights disposed of on
28/08/2018 as the result of the issue of
Ordinary Shares upon the automatic exercise
of the equivalent number of Time-Based
Rights
120,142 Time-Based Rights disposed of on
03/09/2018 as the result of the issue of
Ordinary Shares upon the automatic exercise
of the equivalent number of Time-Based
Rights
Value/Consideration
Note: If consideration is non-cash, provide details and estimated
valuation
N/A
No. of securities held after change
242,022 Time-Based Rights
245,787 Performance Rights
357,232 Ordinary Shares
Nature of change
Example: on-market trade, off-market trade, exercise of options, issue
of securities under dividend reinvestment plan, participation in buy-back
Issue of Ordinary Shares following the
automatic exercise of Time-Based Rights, the
timing of such automatic exercises reflecting
the vesting date of the relevant forfeited
incentive entitlements from Ms Hrdlicka's
former employer
Part 2 – Change of director’s interests in contracts
Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should
be disclosed in this part.
Detail of contract
n/a
Nature of interest
n/a
Name of registered holder
(if issued securities)
n/a
Date of change
n/a
No. and class of securities to which
interest related prior to change
Note: Details are only required for a contract in
relation to which the interest has changed
n/a
Interest acquired
n/a
Interest disposed
n/a
Value/Consideration
Note: If consideration is non-cash, provide details
and an estimated valuation
n/a
Appendix 3Y
Change of Director’s Interest Notice
+ See chapter 19 for defined terms.
01/01/2011 Appendix 3Y Page 3
Interest after change
n/a
Part 3 –
+
Closed period
Were the interests in the securities or contracts detailed
above traded during a
+
closed period where prior written
clearance was required?
No
If so, was prior written clearance provided to allow the trade
to proceed during this period?
n/a
If prior written clearance was provided, on what date was
this provided?
n/a
Data sourced from publicly available filings. Our datasets may not be complete. Automated analysis can produce errors. If you believe any data on this page is incorrect, please contact us at hello@nzxplorer.co.nz. For informational purposes only. Not investment advice.
Other issuers discussed similar conditions around this time
Matched by meaning across NZX announcement text, not keywords — based on our semantic index of announcement bodies.
- MHJ — Michael Hill International Limited: Senior Manager Notice2018-10-28
“Ongoing Disclosure Notice Disclosure of Directors and Senior Managers Relevant Interests Sections 297(1) and 298(1), Financial Markets Conduct Act 2013 To NZX Limited; and Name of listed issuer: Michael Hill International Limited Date this disclosure made: 25-Oct-18 Date of la…”
- FPH — Fisher & Paykel Healthcare Corporation Limited: D&O Ongoing Disclosure – Paul Shearer2018-06-14
“Ongoing Disclosure Notice Disclosure of Directors and Senior Managers Relevant Interests Sections 297(2) and 298(2), Financial Markets Conduct Act 2013 To NZX Limited; and Name of listed issuer: Fisher & Paykel Healthcare Corporation Limited Date this disclosure made: Thursday,…”
- NZX — NZX Limited: D&O Ongoing Disclosures – Multiple2018-06-14
“Ongoing Disclosure Notice Disclosure of Directors and Senior Managers Relevant Interests Sections 297(2) and 298(2), Financial Markets Conduct Act 2013 To NZX Limited; and Name of listed issuer: NZX Limited Date this disclosure made: 15-Jun-18 Date of last disclosure: 3-May-1…”